Jeffrey Farma Appointed Chief of the Division of General Surgery at Fox Chase Cancer Center

Jeffrey Farma, MD, FACS
Dr. Farma has been an integral part of Fox Chase for more than two decades, first as a medical student. He began his role as chief of general surgery on August 1.

PHILADELPHIA (August 22, 2018)— Jeffrey Farma, MD, surgical oncologist at Fox Chase Cancer Center, has been appointed chief of the Division of General Surgery within the Department of Surgery.

Farma joined the Division of General Surgery in 2009 and has built a career as a leading clinical expert in complex surgical oncology, as well as a clinical researcher and educator. He has served as the Society of Surgical Oncology (SSO) fellowship program director since 2013 and has a national and growing international reputation, having authored or co-authored more than 150 peer reviewed publications, chapters, and abstracts. He specializes in treating colorectal cancer, melanoma, sarcoma, and minimally invasive and robotic surgery.

In addition to his new role, Farma serves in several leadership positions at Fox Chase and within the oncology field. He is co-director of the Fox Chase Melanoma and Skin Cancer program, a member of the National Comprehensive Cancer Network (NCCN) panel on non-melanoma skin cancer, and an award-winning advocate and fundraiser for area sarcoma, colorectal cancer, and skin cancer organizations.

Farma has been an integral part of Fox Chase for more than two decades, first as a medical student, then as a resident. He returned to Fox Chase as an attending surgeon after completing his residency in general surgery at Temple University Hospital and surgical oncology fellowships at Moffitt Cancer Center in Tampa and the National Cancer Institute in Bethesda, Maryland.

Farma began his role as chief of general surgery on August 1.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text